Results 41 to 50 of about 530,449 (156)
Respirology Case Reports, Volume 14, Issue 10, October 2026.Our case describes a rare lung co‐infection caused by Aspergillus and Mucorales in a 61‐year‐old man with uncontrolled diabetes and chronic kidney disease. The diagnosis was made by BAL PCR and biopsy. Despite antifungal treatment, the patient worsened and died.
Vinay Venugopal +7 more
wiley +1 more source
A case report of pulmonary mucormycosis
APIK Journal of Internal Medicine, 2020 Pulmonary mucormycosis is a relatively rare pulmonary fungal disease which is difficult to diagnose and lacks effective treatment. The present study reports that the case of a 57-year-old patient who was treated successfully for pulmonary mucormycosis in
Surajsingh Ravindra Taur +2 more
doaj +1 more source
Brazilian Journal of Infectious Diseases, 2012 Pulmonary mucormycosis is a very rare clinical condition in patients without underlying risk factors. A limited number of cases have been reported in predominantly elderly patients; history of smoking appears to be a common feature. A case of non-smoking
Lu Zhang +4 more
doaj +1 more source
Endobronchial mucormycosis: A rare clinical entity diagnosed by endobronchial cryobiopsy
Respiratory Medicine Case Reports, 2022 Mucormycosis is a rare fungal infection caused by fungi of the order Mucorales. The rhino-cerebral form of mucormycosis is most commonly seen in patients with diabetes mellitus, whereas pulmonary mucormycosis is a rare manifestation in patients with ...
Awais Bajwa +5 more
doaj +1 more source
, 2012 Rhinocerebral mucormycosis is a rare, progressive and fatal opportunistic fungal infection. It has high morbidity and mortality. Early diagnosis, medical and surgical management is neces-sary for improving prognosis. We reported two cases.
Buket Tuğan Yıldız +2 more
core +1 more source
Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden
ChemFoodChem, Volume 2, Issue 3, September 2026.ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley +1 more source
Inhibition of EGFR Signaling Protects from Mucormycosis
mBio, 2018 Mucormycosis is a life-threatening, invasive fungal infection that is caused by various species belonging to the order Mucorales. Rhizopus species are the most common cause of the disease, responsible for approximately 70% of all cases of mucormycosis ...
Tonya N. Watkins +11 more
doaj +1 more source
Pulmonary Mucormycosis: An Emerging Infection
, 2012 Mucormycosis is a rare, but emerging, life-threatening, rapidly progressive, angioinvasive fungal infection that usually occurs in immunocompromised patients.
Syed Hassan +5 more
core +1 more source
Pulmonary Mucormycosis with Diabetes Mellitus: A Case Report [PDF]
, 2018 Mucormycosis is an uncommon but life threatening fungal infection that generally occurs mostly in immunocompromised patients. Patients do not respond to the antibiotics and so the condition may prove to be fatal if not timely detected. In this report, we
Shikha Jain, Bharat Sharma
core +1 more source
Mycoses, Volume 69, Issue 9, September 2026.ABSTRACT Background Central nervous system (CNS) aspergillosis is a life‐threatening infection with mortality rates exceeding 50%, especially in immunocompromised patients. Significant challenges persist due to limited antifungal drug penetration into the CNS, emerging resistance, and diagnostic delays, despite advancements in therapy and diagnostics ...
Moustafa A. Mansour +5 more
wiley +1 more source